Results 231 to 240 of about 9,354,751 (270)
Some of the next articles are maybe not open access.
Rituximab in ANCA-Associated Vasculitis
Current Rheumatology Reports, 2017The purpose of this review is to describe the efficacy and safety of rituximab (RTX) as a remission induction and maintenance therapy in ANCA-associated vasculitis (AAV).A PubMed search was carried out to track down articles published between February 2006 and February 2016.
Romina I, Hassan, Angelo L, Gaffo
openaire +2 more sources
The Lancet Rheumatology, 2023
Considerable variability exists in the way health-care providers treat patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Latin America.
S. Magri +16 more
semanticscholar +1 more source
Considerable variability exists in the way health-care providers treat patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Latin America.
S. Magri +16 more
semanticscholar +1 more source
Classification of ANCA-Associated Vasculitis
Current Rheumatology Reports, 2013Classification of the ANCA-associated vasculitides remains controversial. Existing systems, developed by the American College of Rheumatology (ACR) in 1990, the Chapel Hill Consensus Conference (CHCC) in 1994 and updated in 2012, and the European Medicines Agency algorithm, all have deficiencies, especially when applied to unselected patients.
Irfan, Khan, Richard A, Watts
openaire +2 more sources
ANCA associated vasculitis (AAV): a review for internists
Postgraduate medicine, 2022Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) compromise a rare group of necrotizing small to medium vessel vasculitides that constitute three distinct disorders: granulomatosis with polyangiitis (GPA) (formerly known as Wegener’
Kinanah Yaseen, B. Mandell
semanticscholar +1 more source
2009
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +1 more source
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +1 more source
Treatment of ANCA-associated vasculitis
Nature Reviews Nephrology, 2013Antineutrophil cytoplasmic autoantibody (ANCA)-associated diseases are small-vessel vasculitides, encompassing granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
Ulf, Schönermarck +2 more
openaire +2 more sources
Advances in Kidney Disease and Health
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts.
Purva Sharma, Reza Zonozi, Duvuru Geetha
openaire +2 more sources
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts.
Purva Sharma, Reza Zonozi, Duvuru Geetha
openaire +2 more sources
Epidemiology of ANCA-associated Vasculitis
Rheumatic Disease Clinics of North America, 2010The epidemiology of the antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), comprising Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome, poses considerable challenges to epidemiologists. These challenges include the difficulty of defining a case with a lack of clear distinction between the different ...
Ntatsaki, Eleana +2 more
openaire +3 more sources
Drug- and vaccine induced ANCA-associated vasculitis: An overview.
Autoimmunity ReviewsMany different drugs and/or vaccines may cause vasculitis which can be sometimes very severe. The clinical presentation varies from isolated skin vasculitis to multi-organ involvement with pulmonary-renal manifestations and/or cerebral vasculitis ...
Jan Willem Cohen Tervaert
semanticscholar +1 more source
Pathogenesis of ANCA-Associated Vasculitis
Current Rheumatology Reports, 2012Antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitides (AAV) are a group of systemic vasculitis syndromes characterized by inflammation and necrosis of blood vessel walls. Genetic, epigenetic, and environmental factors contribute to the etiology and pathogenesis of AAV.
Rodrigo, Cartin-Ceba +2 more
openaire +2 more sources

